- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cochlear Ltd (COH)
Cochlear Ltd stock price live, this page displays ASX COH stock exchange data. View the COH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cochlear Ltd real time stock price chart below.
What Is the Cochlear Ltd Stock Price Today?
The Cochlear Ltd stock price today is 135.77.
What Is the Stock Symbol for Cochlear Ltd?
The stock symbol for Cochlear Ltd is "COH."
What Stock Exchange Does Cochlear Ltd Trade On?
Cochlear Ltd is listed and trades on the Sydney stock exchange.
Is Cochlear Ltd a Good Stock to Buy?
Determining whether Cochlear Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COH quote. (ISIN: AU000000COH5)
What Is the Cochlear Ltd Stock Price Today?
The Cochlear Ltd stock price today is 135.77.
What Is the Stock Symbol for Cochlear Ltd?
The stock symbol for Cochlear Ltd is "COH."
What Stock Exchange Does Cochlear Ltd Trade On?
Cochlear Ltd is listed and trades on the Sydney stock exchange.
Is Cochlear Ltd a Good Stock to Buy?
Determining whether Cochlear Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COH quote. (ISIN: AU000000COH5)
135.77
+0.29(+0.21%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
133.03
136.99
52 wk Range
88.74
303.89
COH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
133.03136.99
52 wk Range
88.74303.89
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.54%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.54%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
COH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
140.04
Upside
+3.14%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Cochlear Limited receives Investment Bank Analyst Rating Update- Investing.com
Pro
Cochlear Limited receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Cochlear Limited receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cochlear Limited receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Cochlear Limited receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Analyst Ratings
1 Buy
14 Hold
1 Sell
Ratings:
16 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 140.04
(+3.14% Upside)
Cochlear Ltd Earnings Call Summary for H2/2026
- FY26 sales rose 2% to AUD 2.3B; underlying net profit AUD 322M with margin at 14%, below 18% medium-term target due to mix and China pricing.
- Free cash flow more than doubled; operating cash flow improved AUD 130M as inventory fell 13% and working capital discipline strengthened.
- Nexa platform exceeded expectations, capturing over 95% of developed market implant sales by June 2026, supporting future growth initiatives.
- FY27 guidance: low single-digit revenue growth, underlying net profit AUD 330-350M, gross margin 70-71% amid cost savings and continued R&D investment.
- Western Europe revenue fell 8% on healthcare constraints; China pricing pressure and Middle East disruption weighed on emerging markets despite U.S. resilience.
Last Updated: 2026-08-17, 11:20 p/m
Read Full TranscriptEarnings
Latest Release
Feb 12, 2026
EPS / Forecast
2.47 / 288.50
Revenue / Forecast
1.17B / 1.13B
Compare COH to Peers and Sector
Metrics to compare | COH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCOHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 60.3x | 21.4x | −0.4x | |
PEG Ratio | −0.97 | 0.10 | 0.00 | |
Price/Book | 5.1x | 2.5x | 2.6x | |
Price / LTM Sales | 3.8x | 2.0x | 3.1x | |
Upside (Analyst Target) | 2.5% | 125.0% | 48.6% | |
Fair Value Upside | Unlock | 8.5% | 5.8% | Unlock |
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cochlear (COH) Stock Price Today?
The Cochlear stock price today is 135.77 AUD.
What Stock Exchange Does Cochlear Trade On?
Cochlear is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Cochlear?
The stock symbol for Cochlear is "COH."
Does Cochlear Pay Dividends? What’s The Current Dividend Yield?
The Cochlear dividend yield is 2.54%.
What Is the Cochlear Market Cap?
As of today, Cochlear market cap is 8.88B AUD.
What Is Cochlear's Earnings Per Share (TTM)?
The Cochlear EPS (TTM) is 2.25.
From a Technical Analysis Perspective, Is COH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Cochlear Stock Split?
Cochlear has split 0 times.
How Many Employees Does Cochlear Have?
Cochlear has 5400 employees.
What is the current trading status of Cochlear (COH)?
As of Aug 24, 2026, Cochlear (COH) is trading at a price of 135.77 AUD, with a previous close of 135.48 AUD. The stock has fluctuated within a day range of 133.03 AUD to 136.99 AUD, while its 52-week range spans from 88.74 AUD to 303.89 AUD.
What Is Cochlear (COH) Price Target According to Analysts?
The average 12-month price target for Cochlear is 140.04 AUD, with a high estimate of 180 AUD and a low estimate of 110 AUD. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +3.14% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.